Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens. (Q44138330)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2009

Language	Label	Description	Also known as
English	Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.	scientific article published on 25 August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

based on heuristic

inferred from title

Adam K Wheatley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Stephen J. Kent

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Carly Siebentritt

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

object named as

Rob J Center

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Shahan M Campbell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Adriana J Gaeguta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Viv Peut

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sheilajen Alcantara

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Damian F J Purcell

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

25 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6605-6612

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712773%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Combination DNA plus protein HIV vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

The Preferential Induction of a Th1 Immune Response by DNA-Based Immunization Is Mediated by the Immunostimulatory Effect of Plasmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Combination of HIV‐1–Specific CD4 Th1 Cell Responses and IgG2 Antibodies Is the Best Predictor for Persistence of Long‐Term Nonprogression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp120 in humans and macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.016

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44138330&oldid=2107014373"